|
Mr. Hall is Angiotech's Chief Compliance Officer and acts as an officer and treasurer of the company. He is responsible for Angiotech's overall financial compliance and acts as a key liaison to government and community agencies .Mr. Hall has been an integral part of many of the company's financial and corporate achievements while previously serving as Chief Financial Officer, which include its Initial Public Offering in 1997, listings on the NASDAQ and TSX stock exchanges, and two successful financings.
Prior to Angiotech, he was the Corporate Development Officer for ID Biomedical Corporation, an institutional research analyst and corporate financier for a national institutional brokerage company, and an equity portfolio manager for a large Canadian insurance company.
Mr. Hall is highly committed to governmental policy issues related to the biotech industry. He currently serves as the Chairman of The BC Biotech Association and Chairman of the Biotech Industry Advisory Committee to the BC Competition Council. Mr. Hall is also member of the University of British Columbia's Tech Equity Investment Committee.
Mr. Hall received his BA in Economics (Honours) in 1975 and BComm in Finance (Honours) from the University of Manitoba in 1977. | 